The global pharmacovigilance market is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research. The market for pharmacovigilance is experiencing rapid growth attributed to a rise in application for spontaneous reporting, electronic health record (HER) mining, cohort event monitoring, and intensified adverse drug reaction (ADR) reporting, among others
https://www.emergenresearch.co....m/industry-report/ph
![image](https://sharingfield.com/upload/photos/2022/04/1mznKA8GOuVmPxvN6aM2_04_c2f056b3701cde843fa6a813cd2114ff_image.jpg)